NCT00374036View on ClinicalTrials.gov

Metastatic Gastric Cancer FFCD 03-07

PHASE3CompletedINTERVENTIONAL

Enrollment

416

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Stomach CancerNeoplasm Metastasis

Interventions

DRUG

ECC

capecitabine

DRUG

FOLFIRI

Irinotecan

Trial Locations (1)

Unknown

CHU Toulouse, Toulouse

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Federation Francophone de Cancerologie Digestive

OTHER

collaborator

Roche Pharma AG

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

University Hospital, Toulouse

OTHER

NCT00374036 - Metastatic Gastric Cancer FFCD 03-07 | Biotech Hunter | Biotech Hunter